Home Fear & Greed Pools Wallets Advertise Facebook Twitter Telegram Reddit Youtube
Market Cap:
24h Vol:
Cryptocurrencies: 7227
Markets: 116349
Crypto Currency Tracker logo Crypto Currency Tracker logo
ENG
EST
RUS
TUR
DEU
KOR
ITA
USD
USD
AED
AFN
ALL
AMD
ANG
AOA
ARS
AUD
AWG
AZN
BAM
BBD
BDT
BGN
BHD
BIF
BMD
BND
BOB
BRL
BTN
BWP
BYN
BZD
CAD
CDF
CHF
CLF
CLP
CNH
CNY
COP
CRC
CUC
CUP
CVE
CZK
DJF
DKK
DOP
DZD
EGP
ERN
ETB
EUR
FJD
FKP
GBP
GEL
GHS
GIP
GMD
GNF
GTQ
GYD
HKD
HNL
HRK
HTG
HUF
IDR
ILS
IMP
INR
ISK
JMD
JOD
JPY
KES
KGS
KHR
KMF
KPW
KRW
KWD
KYD
KZT
LAK
LBP
LKR
LRD
LSL
LYD
MAD
MDL
MGA
MKD
MMK
MNT
MOP
MRO
MRU
MUR
MVR
MWK
MXN
MYR
MZN
NAD
NGN
NIO
NOK
NPR
NZD
OMR
PAB
PEN
PGK
PHP
PKR
PLN
PYG
QAR
RON
RSD
RUB
RWF
SAR
SBD
SCR
SDG
SEK
SGD
SHP
SLL
SRD
SSP
STD
STN
SVC
SYP
SZL
THB
TJS
TMT
TND
TOP
TRY
TTD
TWD
TZS
UAH
UGX
UYU
UZS
VEF
VND
VES
VUV
WST
ZAR
ZMW
ZWL
Market Cap
24h Vol
7227
Cryptocurrencies
58.6%
Bitcoin Share
CoinDesk 2025-09-30 13:29:00

CoreWeave Jumps 8% Pre-Market on Meta AI Deal, Core Scientific Merger Looms

CoreWeave Jumps 8% Pre-Market on Meta AI Deal, Core Scientific Merger Looms

CoreWeave (CRWV), an AI-focused cloud computing company, secured a $14.2 billion deal with Meta Platforms (META) to supply Nvidia’s latest GB300 systems, according to a Bloomberg report citing an interview with CEO Michael Intrator. Shares in the company, which is in the process of buying Core Scientific (CORZ) for $9 billion , jumped more than 8% pre-market to $132, more than triple the value of its March initial public offering. The agreement diversifies its revenue away from Microsoft (MSFT), historically its largest customer, and follows a multibillion-dollar commitment from OpenAI, according to Bloomberg. In addition, Evercore ISI initiated coverage on CoreWeave with an outperform rating and a $175 price target. Core Scientific scheduled a special shareholder meeting for Oct. 30 to vote on the takeover, according to a Friday SEC filing .

Most Read News

Market Cap
24h Vol
58.6%
Bitcoin Share
0
Today News
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.